United States

Zoetis Appoints Dr. Richard E. Goldstein as Executive Director and Chief Medical Officer of U.S. Diagnostics

Internationally-recognized veterinarian, author and teacher brings unique passion and innovation to the Diagnostics Team

PARSIPPANY, NJ – Jan. 8, 2018 – Zoetis today announced the appointment of Richard E. Goldstein, DVM, DACVIM, DECVIM-CA to the position of Executive Director and Chief Medical Officer of U.S. Diagnostics, effective February 5, 2018. Dr. Goldstein will lead the U.S. Diagnostics team in expanding its product portfolio and will spearhead the division’s studies and publishing opportunities.

“Dr. Goldstein is a well-respected, internationally-renowned veterinarian in small animal internal medicine and we’re honored to have him join our Zoetis team,” Lisa Lee, vice president, U.S. Diagnostics and Business Solutions at Zoetis. “His award-winning work, research and passion for preventing genetic and infectious diseases make him an ideal fit for our company as we continue to develop innovative technologies and solutions to diagnose disease as well as treat and improve the lives of pets.”

In his role at Zoetis, Dr. Goldstein will work closely with the U.S. Companion Animal Division to develop educational events for sales and marketing, while leading efforts to bring the company’s unique “Predict, Prevent, Detect and Treat” strategy to life. He will also manage the Key Opinion Leader program. Dr. Goldstein and the team will continue to emphasize digital innovation, diagnostics, genetic tests, and biodevices as important tools to help veterinarians make better healthcare decisions informed by data.

“I’ve always been incredibly impressed with Zoetis and its industry-leading approach to improving overall animal health,” said Dr. Goldstein. “I am excited and energized about taking on this new role, and I look forward to continuing the Diagnostics team mission to stay on the cutting edge of technology and novel concepts to fight genetic and infectious diseases in pets.”

Prior to joining Zoetis, Dr. Goldstein spent 12 years as a Professor of Small Animal Medicine at the Cornell University College of Veterinary Medicine and the last six years as the Chief Medical Officer of the nationally renowned Animal Medical Center in New York City.

Dr. Goldstein received his B.S. degree from the Institute of Biological Sciences, Hebrew University of Jerusalem, and his DVM from Koret School of Veterinary Medicine, Hebrew University of Jerusalem. He is board certified in Small Animal Internal Medicine by both the American College of Veterinary Internal Medicine and the European College of Veterinary Internal Medicine, Companion Animals.

Dr. Goldstein is the recipient of several prestigious awards, including the American College of Veterinary Internal Medicine, Endocrinology Society Research Award and the Norden Distinguished Teaching Award. His research and clinical interests throughout his career have been focused on improving the ability of veterinarians to detect and prevent genetic and infectious diseases in companion animals through the development of multiple novel diagnostic tests and vaccines. His most significant impact has been in infectious disease through his work on both canine Lyme disease and leptospirosis, for which he has achieved international recognition. Dr. Goldstein is active in the One Health community and serves on the scientific advisory boards of the One Health Commission, as well as the Global Lyme Alliance.

About Zoetis
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.

For further information contact:
Colleen T. White
973.822.7203
colleen.white@zoetis.com

Danielle Paleafico
973-588-2000
dpaleafico@coynepr.com